Biotech
Drug developers with approved medicines, built mainly on biologic and genetic science.
Pogrupowane z pomocą modelu AI i sprawdzone przez naszą redakcję. Wiersz pod każdą spółką mówi, dlaczego się tu znalazła.
Sells medicines for HIV, liver disease and cancer
Develops and sells therapies for neurological diseases
Develops and sells therapies for neurological and endocrine disorders
Develops and sells cancer therapies
Develops and sells neuroscience and oncology therapies
Licenses drug delivery technology and sells enzyme-based therapies
Develops and sells topical gene therapies for rare diseases
Develops and sells cortisol-modulating therapies
Develops and sells cystic fibrosis and other medicines
Develops and sells RNAi therapeutics
Develops therapies for genetic diseases
Develops and sells therapies for rare genetic diseases
Develops and sells antibody therapies for eye, allergy and cancer conditions
Develops mRNA vaccines and therapies
Develops and sells therapies for rare lung diseases
Sells therapies for pulmonary arterial hypertension
Develops and sells oncology and inflammation therapies
Develops and sells endocrinology rare disease therapies
Develops mRNA vaccines and cancer therapies
Lists are their owners' own, and notes and comments are opinions. Grades describe businesses from their filings; nothing here is a recommendation to buy or sell.
DiscussionNo comments yet
Be civil and stick to the companies. Comments are opinions, not advice.